/Viatris%20Inc%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
Valued at a market cap of $15.2 billion, Viatris Inc. (VTRS) is a global pharmaceutical and healthcare company headquartered in Pennsylvania. It operates at scale across 120+ countries, focusing on expanding access to affordable medicines worldwide
Companies worth $10 billion or more are typically classified as “large-cap stocks,” and Viatris fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the specialty & generic drug manufacturers industry. Its competitive strength lies in its global scale, diversified portfolio, and cost-efficient manufacturing model, enabling it to deliver affordable medicines across both developed and emerging markets.